Star Health and Allied Insurance Company Limited

Star Health and Allied Insurance Company Limited (STARHEALTH) financial statements and selected valuation metrics from NSE/BSE exchange filings through 31 March 2026.

Financial ServicesFinancial ServicesInsuranceGeneral Insurance

starhealth.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-02

Stock price
₹562.95
Stock P/E
258.2

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Insurance layout · ₹ Cr · quarterly

MetricMar 2025Jun 2025Sept 2025Dec 2025
Premium4,820 Cr3,457 Cr4,233 Cr4,361 Cr
Expenses684 Cr620 Cr676 Cr780 Cr
Operating profit4,136 Cr2,838 Cr3,557 Cr3,581 Cr
Investment income
Other income2 Cr0.36 Cr3 Cr2 Cr
Profit before tax-0.87 Cr352 Cr78 Cr173 Cr
Tax %158.6%25.4%29.3%26.1%
Net profit
EPS (₹)₹0.01₹4.47₹0.93₹2.18

Profit & loss (annual)

Annual insurance P&L · TTM where available · ₹ Cr

MetricMar 2025TTM
Premium15,525 CrSign in for TTM
Expenses2,541 CrSign in for TTM
Operating profit12,985 CrSign in for TTM
Investment incomeSign in for TTM
Other income6 CrSign in for TTM
Profit before tax861 CrSign in for TTM
Tax %25.0%Sign in for TTM
Net profitSign in for TTM
EPS (₹)₹11.01Sign in for TTM
Dividend payout %Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2025
Equity capital
Reserves6,436 Cr
Borrowings470 Cr
Other liabilities
Total liabilities20,785 Cr
Fixed assets (net)185 Cr
CWIP
Investments17,898 Cr
Cash & bank668 Cr
Other assets2,033 Cr
Total assets20,785 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2025
Cash from operating activity1,379 Cr
Cash from investing-1,151 Cr
Cash from financing-4 Cr
Net cash flow224 Cr
Free cash flow (OCF − Capex)1,296 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2025
ROCE %
ROE %
Debtor days
Inventory days
Days payable
Cash conversion cycle
Debt / equity
Current ratio0.57
Net debt / EBITDA

Compare with peers

Loading peers…